X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
humans (7) 7
diagnosis (6) 6
screening (6) 6
familial hypercholesterolaemia (5) 5
hyperlipoproteinemia type ii - diagnosis (5) 5
hyperlipoproteinemia type ii - therapy (5) 5
anticholesteremic agents - therapeutic use (4) 4
assessment (4) 4
association expert panel (4) 4
cardiac & cardiovascular systems (4) 4
models of care (4) 4
peripheral vascular disease (4) 4
treatment (4) 4
triglycerides (4) 4
adults (3) 3
cardiovascular (3) 3
children (3) 3
cholesterol (3) 3
familial hypercholesterolemia (3) 3
genetic aspects (3) 3
guidelines (3) 3
hypercholesterolemia (3) 3
international guidance (3) 3
lipoproteins (3) 3
pharmacology & pharmacy (3) 3
prevalence (3) 3
risk (3) 3
risk factors (3) 3
adult (2) 2
atherogenic dyslipidemia (2) 2
b synthesis inhibitor (2) 2
cardiovascular disease (2) 2
cardiovascular risk prediction (2) 2
cardiovascular-disease (2) 2
care and treatment (2) 2
child (2) 2
cooperative behavior (2) 2
cost-effectiveness analysis (2) 2
density-lipoprotein cholesterol (2) 2
diabetes (2) 2
dyslipidemia (2) 2
europe - epidemiology (2) 2
europe, eastern - epidemiology (2) 2
general-population (2) 2
hyperlipoproteinemia type ii - epidemiology (2) 2
hyperlipoproteinemia type ii - genetics (2) 2
inflammation (2) 2
international cooperation (2) 2
internationality (2) 2
intima-media thickness (2) 2
lipids (2) 2
long-term safety (2) 2
management (2) 2
mass screening (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
monoclonal-antibody (2) 2
myocardial-infarction (2) 2
pemafibrate (2) 2
prominent (2) 2
recommendations (2) 2
remnant cholesterol (2) 2
residual cardiovascular risk (2) 2
selective peroxisome proliferator-activated receptor alpha modulator (2) 2
spparmalpha (2) 2
statins (2) 2
subtilisin/kexin type 9 (2) 2
visceral obesity (2) 2
access to information (1) 1
adolescent (1) 1
age factors (1) 1
agonists (1) 1
all-cause mortality (1) 1
anticholesteremic agents - administration & dosage (1) 1
anticholesteremic agents - adverse effects (1) 1
anticholesteremic agents - standards (1) 1
antilipemic agents (1) 1
apolipoproteins (1) 1
arteriosclerosis (1) 1
atherosclerosis (1) 1
atherosclerosis - drug therapy (1) 1
beam computed-tomography (1) 1
bioavailability (1) 1
biomarkers - blood (1) 1
blood component removal (1) 1
blood component removal - adverse effects (1) 1
blood component removal - standards (1) 1
blood pressure (1) 1
c-reactive protein (1) 1
cardiac and cardiovascular systems (1) 1
cardiology and cardiovascular medicine (1) 1
cardiovascular diseases (1) 1
cardiovascular risk-factors (1) 1
chemical compounds (1) 1
cholesterol, ldl - blood (1) 1
cholesterol, ldl - metabolism (1) 1
chronic kidney-disease (1) 1
clinical medicine (1) 1
clinician (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue Suppl_1 Suppl 1, pp. A14954 - A14954
IntroductionHigh apoC3 inhibits the clearance of triglyceride (TG)-rich lipoproteins and is associated with cardiovascular disease. The EVOLVE I trial... 
Journal Article
Journal Article
by Vallejo-Vaz, Antonio J and De Marco, Martina and Stevens, Christophe A.T and Akram, Asif and Freiberger, Tomas and Hovingh, G. Kees and Kastelein, John J.P and Mata, Pedro and Raal, Frederick J and Santos, Raul D and Santos, Lourdes E and Soran, Handrean and Watts, Gerald F and Abifadel, Marianne and Aguilar-Salinas, Carlos A and Al-khnifsawi, Mutaz and AlKindi, Fahad A and Alnouri, Fahad and Alonso, Rodrigo and Al-Rasadi, Khalid and Al-Sarraf, Ahmad and Ashavaid, Tester F and Binder, Christoph J and Bogsrud, Martin P and Bourbon, Mafalda and Bruckert, Eric and Chlebus, Krzysztof and Corral, Pablo and Descamps, Olivier and Durst, Ronen and Ezhov, Marat and Fras, Zlatko and Genest, Jacques and Groselj, Urh and Harada-Shiba, Mariko and Kayikcioglu, Meral and Lalic, Katarina and Lam, Carolyn S.P and Latkovskis, Gustavs and Laufs, Ulrich and Liberopoulos, Evangelos and Lin, Jie and Maher, Vincent and Majano, Nelson and Marais, A. David and März, Winfried and Mirrakhimov, Erkin and Miserez, André R and Mitchenko, Olena and Nawawi, Hapizah M and Nordestgaard, Børge G and Paragh, György and Petrulioniene, Zaneta and Pojskic, Belma and Postadzhiyan, Arman and Reda, Ashraf and Reiner, Željko and Sadoh, Wilson E and Sahebkar, Amirhossein and Shehab, Abdullah and Shek, Aleksander B and Stoll, Mario and Su, Ta-Chen and Subramaniam, Tavintharan and Susekov, Andrey V and Symeonides, Phivos and Tilney, Myra and Tomlinson, Brian and Truong, Thanh-Huong and Tselepis, Alexandros D and Tybjærg-Hansen, Anne and Vázquez-Cárdenas, Alejandra and Viigimaa, Margus and Vohnout, Branislav and Widén, Elisabeth and Yamashita, Shizuya and Banach, Maciej and Gaita, Dan and Jiang, Lixin and Nilsson, Lennart and Schunkert, Heribert and Tokgözoğlu, Lale and Car, Josip and Catapano, Alberico L and Ray, Kausik K and EAS Familial Hypercholesterolaemia and EAS Familial Hypercholestero and EAS Familial Hypercholesterolaemia Studies Collaboration and EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators and Avdelningen för kardiovaskulär medicin and Medicinska fakulteten and Region Östergötland and Linköpings universitet and Institutionen för medicin och hälsa and Hjärt- och Medicincentrum and Kardiologiska kliniken US
Atherosclerosis, ISSN 0021-9150, 10/2018, Volume 277, pp. 234 - 255
Journal Article
Cardiovascular Diabetology, 06/2019, Volume 18, Issue 1, pp. 1 - 20
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 03/2018, Volume 12, Issue 2, pp. 321 - 330
Adult patients with severe hypertriglyceridemia (SHTG) are at increased risk of developing acute pancreatitis and cardiovascular disease. Omega-3 carboxylic... 
Triglyceride | Hypertriglyceridemia | Non-high-density lipoprotein cholesterol | Omega-3 carboxylic acids | ETHYL-ESTERS | TRIACYLGLYCEROLS | TRIGLYCERIDES | RISK | FORMULATION | BIOAVAILABILITY | HEART-DISEASE | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | LOW-FAT DIET | LIPOPROTEINS
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2013, Volume 171, Issue 3, pp. 309 - 325
Journal Article